Ken Griffin Senseonics Holdings, Inc. Transaction History

Citadel Advisors LLC

$618 Billion
Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 165,300 shares of SENS stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,300

Previous 317,500 47.94%

Holding current value

$1.03 Million

Previous $152,000 52.63%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.43 - $0.58 $456,283 - $615,451	1,061,124 Added 83.11%	2,337,853 $1.03 Million
Q2 2025 Aug 14, 2025	BUY	$0.48 - $0.77 $187,441 - $300,688	390,504 Added 44.06%	1,276,729 $612,000
Q1 2025 May 15, 2025	SELL	$0.43 - $1.31 $281,207 - $856,702	-653,971 Reduced 42.46%	886,225 $584,000
Q4 2024 Feb 14, 2025	BUY	$0.25 - $0.59 $365,679 - $863,003	1,462,718 Added 1887.91%	1,540,196 $800,000
Q3 2024 Nov 14, 2024	BUY	$0.32 - $0.49 $8,910 - $13,644	27,846 Added 56.1%	77,478 $27,000

Q2 2024 Aug 14, 2024	SELL	$0.37 - $0.52 $301,924 - $424,325	-816,011 Reduced 94.27%	49,632 $19,000
Q1 2024 May 15, 2024	BUY	$0.5 - $0.73 $45,296 - $66,132	90,593 Added 11.69%	865,643 $458,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $0.7 $371,302 - $541,482	773,547 Added 51466.87%	775,050 $441,000
Q3 2023 Nov 14, 2023	BUY	$0.5 - $1.05 $723 - $1,519	1,447 Added 2583.93%	1,503 $0
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.89 $30 - $49	56 New	56 $0
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.34 $227,831 - $318,014	237,324 Added 191.78%	361,070 $371,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $126,220 - $275,953	123,746 New	123,746 $164,000
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $1.65 Million - $3.98 Million	-1,072,026 Reduced 34.63%	2,023,550 $3.99 Million
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $7.71 Million - $11.7 Million	2,986,650 Added 2741.91%	3,095,576 $8.27 Million
Q3 2021 Nov 15, 2021	SELL	$2.77 - $4.05 $257,704 - $376,787	-93,034 Reduced 46.07%	108,926 $369,000
Q2 2021 Aug 16, 2021	SELL	$1.71 - $4.14 $2.03 Million - $4.91 Million	-1,184,874 Reduced 85.44%	201,960 $775,000
Q1 2021 May 17, 2021	BUY	$0.85 - $5.27 $1.05 Million - $6.51 Million	1,234,670 Added 811.41%	1,386,834 $3.66 Million
Q4 2020 Feb 16, 2021	BUY	$0.36 - $0.95 $6,689 - $17,652	18,582 Added 13.91%	152,164 $133,000
Q1 2020 May 15, 2020	BUY	$0.56 - $1.62 $60,565 - $175,207	108,153 Added 425.31%	133,582 $85,000
Q4 2019 Feb 14, 2020	SELL	$0.83 - $1.3 $12,376 - $19,384	-14,911 Reduced 36.96%	25,429 $23,000
Q3 2019 Nov 14, 2019	SELL	$0.97 - $1.94 $345,335 - $690,671	-356,016 Reduced 89.82%	40,340 $39,000
Q1 2019 May 15, 2019	BUY	$2.3 - $3.27 $837,494 - $1.19 Million	364,128 Added 1129.85%	396,356 $0
Q4 2018 Feb 14, 2019	SELL	$2.49 - $4.54 $36,443 - $66,447	-14,636 Reduced 31.23%	32,228 $83,000
Q3 2018 Nov 13, 2018	BUY	$3.4 - $4.84 $159,337 - $226,821	46,864 New	46,864 $0
Q4 2017 Feb 09, 2018	SELL	$2.43 - $3.54 $147,894 - $215,451	-60,862 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$2.22 - $3.2 $135,113 - $194,758	60,862	60,862 $194,000

Others Institutions Holding SENS

# of Institutions

134

Shares Held

111M

Call Options Held

309K

Put Options Held

372K

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $2.91B
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account